SEC Form 4 · accession 0001559834-26-000001
Xtant Medical Holdings, Inc. · XTNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stavros G. Vizirgianakis
Director
Period of report
Aug 15, 2026
Accepted (ET)
Aug 18, 2026 · 6:09 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001453593
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 15, 2026 | A | 323,275 | $0.00 | A | 7,838,845 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are subject to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on August 15, 2027, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.
- F2Includes 1,843,491 shares issuable upon settlement of DSUs granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting date.